Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Deerfield Mgmt, L.P.'s stake in Cullinan Therapeutics, Inc. fell to 4.95% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Deerfield Mgmt, L.P.'s stake in Cullinan Therapeutics, Inc. fell to 4.95%, 2,927,013 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 4.95%
- Shares
- 2,927,013
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deerfield Mgmt, L.P. | 4.95% | 2,927,013 |
| Deerfield Management Company, L.P. | 4.95% | 2,927,013 |
| Deerfield Partners, L.P. | 4.95% | 2,927,013 |
| James E. Flynn | 4.95% | 2,927,013 |
Source
Related
- Cullinan Therapeutics, Inc.
- Deerfield Mgmt, L.P.
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026